OSE Immunotherapeutics SA's total assets for Q4 2024 were €123.96M, a decrease of -12.04% from the previous quarter. DE:6OP total liabilities were €60.15M for the fiscal quarter, a 1.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.